Salarius Pharmaceuticals Shares Resume Trade
Portfolio Pulse from Benzinga Newsdesk
Salarius Pharmaceuticals (SLRX) shares have resumed trading after a temporary halt.

July 29, 2024 | 2:16 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Salarius Pharmaceuticals (SLRX) shares have resumed trading after a temporary halt.
The resumption of trading for SLRX shares indicates that any issues causing the halt have been resolved. However, without additional context on the reason for the halt, the short-term impact on the stock price is neutral.
CONFIDENCE 90
IMPORTANCE 50
RELEVANCE 100